(Q33492045)

27 July 2017

title

Tumor necrosis factor, interleukin-2, and interferon-gamma in adult varicella (English)

1 reference

27 July 2017

Wallace MR

1

1 reference

27 July 2017

Woelfl I

2

1 reference

27 July 2017

Bowler WA

3

1 reference

27 July 2017

Olson PE

4

1 reference

27 July 2017

Murray NB

5

1 reference

27 July 2017

Brodine SK

6

1 reference

27 July 2017

Oldfield EC 3rd

7

1 reference

27 July 2017

Arvin AM

8

1 reference

27 July 2017

publication date

1 May 1994

1 reference

Journal of Medical Virology

27 July 2017

published in

1 reference

27 July 2017

volume

43

1 reference

27 July 2017

issue

1

1 reference

27 July 2017

page(s)

69-71

1 reference

Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002/JMV.1890430113

Serum tumor necrosis factor in acute and fulminant hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/JMV.1890430113

Activation of Lymphocytes by Varicella-Zoster Virus (VZV): Expression of Interleukin-2 Receptors on Lymphocytes Cultured with VZV Antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/JMV.1890430113

Serum tumor necrosis factor-alpha concentrations in children hospitalized for acute lower respiratory tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/JMV.1890430113

Modulation of host defenses by cytokines: evolving adjuncts in prevention and treatment of serious infections in immunocompromised hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/JMV.1890430113

Treatment of adult varicella with oral acyclovir. A randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/JMV.1890430113

21 January 2018

Identifiers

DOI

10.1002/JMV.1890430113

1 reference

27 July 2017

1 reference